Skip to content

Grafton Plus Dbm Paste

by Osteotech, Inc. 2 variants

510(k) K043048

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

3 ongoing

This device is named in the recall

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK043048 Date23 Nov 2005ClearedStatusActive

Recalls

15 recalls · 3 ongoing · FDA

    • Ongoing Z-0137-2027 FDA Not yet classified initiated 12 Aug 2026

    Medtronic identified through donor record review that the donor for Medtronic batch A62881 did not meet all Medtronic donor eligibility requirements related to the presence of microbial organisms. While the batch passed finished product sterility testing Medtronic is retrieving any unused product manufactured from the donor tissue. Donor bone tissue tested positive for Clostridium butyricum and while tissue did undergo gamma radiation, if implanted, there is a possibility of clostridium infection

    • Ongoing Z-0166-2024 FDA Class II initiated 26 Sep 2023

    Specific serial numbers of GraftonTM DBM product due to the potential that a step during the inspection of the outer Tyvek pouch may not have been performed according to requirements. Based on this, batches may have been released with potential non-conformances in the outer Tyvek pouch.

    • Ongoing Z-1329-2023 FDA Class II initiated 8 Feb 2023

    Potential for packaging non-conformances directly related to the dual-barrier, sterile pouch packaging system. Non-conforming packaging may lead to a breach in the sterile barrier.

  • 12 recalls, same reason

    • Terminated Z-0088-2013 FDA Class II initiated 20 Apr 2012
    • Terminated Z-0091-2013 FDA Class II initiated 20 Apr 2012
    • Terminated Z-0085-2013 FDA Class II initiated 20 Apr 2012
    • Terminated Z-0086-2013 FDA Class II initiated 20 Apr 2012
    • Terminated Z-0094-2013 FDA Class II initiated 20 Apr 2012
    • Terminated Z-0092-2013 FDA Class II initiated 20 Apr 2012
    • Terminated Z-0084-2013 FDA Class II initiated 20 Apr 2012
    • Terminated Z-0090-2013 FDA Class II initiated 20 Apr 2012
    • Terminated Z-0089-2013 FDA Class II initiated 20 Apr 2012
    • Terminated Z-0093-2013 FDA Class II initiated 20 Apr 2012
    • Terminated Z-0083-2013 FDA Class II initiated 20 Apr 2012
    • Terminated Z-0087-2013 FDA Class II initiated 20 Apr 2012

    Multiple lots of GRAFTON and XPANSE , which are used for bone grafting procedures are being recalled because there is a possibility that sterility of the outer surface of the inner pouch may become compromised.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
MBP
Device Class
Class II
Regulation
21 CFR Part 888.3045
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Other devices from Osteotech, Inc.

See all devices from Osteotech, Inc. →